Personalized prognosis stratification of newly diagnosed glioblastoma applying a statistical decision tree model - Takeaways - MDSpire

Personalized prognosis stratification of newly diagnosed glioblastoma applying a statistical decision tree model

  • By

  • Katharina Conrad

  • Ronja Löber-Handwerker

  • Mohammad Hazaymeh

  • Veit Rohde

  • Vesna Malinova

  • April 19, 2024

  • 0 min

Share

  • 1

    Glioblastoma (GBM) is an aggressive brain tumor with heterogeneous clinical manifestations affecting individual survival odds.

  • 2

    Key prognostic factors for GBM include age, clinical status, tumor location, extent of resection, and MGMT promoter methylation.

  • 3

    A prognostication tool was developed to estimate individual survival probabilities for newly diagnosed GBM patients.

  • 4

    The study analyzed a retrospective cohort of GBM patients treated from 2010 to 2021, excluding those with IDH mutations.

  • 5

    Primary outcome measured was overall survival (OS) from diagnosis to death, considering various clinical and radiological factors.

Original Source(s)

Personalized prognosis stratification of newly diagnosed glioblastoma applying a statistical decision tree model

  • by Katharina Conrad, Ronja Löber-Handwerker, Mohammad Hazaymeh, Veit Rohde, Vesna Malinova

  • April 19, 2024

Related Content

Validation of a cervical CDO1/CELF4 methylation test for endometrial cancer: a prospective paired-sample comparison with intrauterine specimen

Potential targets for boron transport in boron neutron capture therapy

Is full adherence mandatory? Real-world outcomes of completing perioperative chemoimmunotherapy in resectable non-small cell lung cancer